UBS Adjusts W. R. Berkley Price Target to $79 From $77
UBS has updated its price target for W. R. Berkley Corporation, raising it to $79 from $77 while maintaining a Neutral rating.
Stocks · News reference
WR Berkley Q3 Adj. EPS $1.17 Beats $1.14 Estimate, Sales $3.739B Miss $3.824B Estimate
WR Berkley (NYSE:WRB) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $1.14 by 2.63 percent. This is a 6.36 percent increase over earnings of $1.10 per share from the same
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
W. R. Berkley: 3 Key Takeaways for Long-Term Investors
W. R. Berkley reported record Q3 2026 underwriting profit of $296 million with double-digit investment portfolio growth. The company achieved 20% operational efficiency gains through AI and data automation in policy processing, benefited from higher fixed income yields on its $24 billion portfolio, and maintained underwriting discipline by reducing reinsurance exposure in soft markets.
Wells Fargo Maintains Underweight on WR Berkley, Raises Price Target to $68
Wells Fargo analyst Elyse Greenspan maintains WR Berkley (NYSE:WRB) with a Underweight and raises the price target from $65 to $68.
These Analysts Revise Their Forecasts On WR Berkley Following Q3 Results
W.R. Berkley beat Q3 EPS estimates but missed revenue. Mizuho raised its target to $73; Evercore cut it to $69.
Evercore ISI Group Maintains Underperform on WR Berkley, Lowers Price Target to $69
Evercore ISI Group analyst David Motemaden maintains WR Berkley (NYSE:WRB) with a Underperform and lowers the price target from $70 to $69.
Mizuho Maintains Neutral on WR Berkley, Raises Price Target to $73
Mizuho analyst Yaron Kinar maintains WR Berkley (NYSE:WRB) with a Neutral and raises the price target from $70 to $73.